Why Is TransMedics Group, Inc. (TMDX) Up 28% Today?
Healthcare's biggest mover today
TransMedics Group, Inc. is the biggest Healthcare gainer on the board today. What follows is what can be sourced about why — and, where nothing can be, that is said plainly rather than filled in.
The move
TMDX trades at $88.24, up +27.9% on the session, with a market capitalisation of $3.06 billion.
Volume is 4.9 times the 30-day average, which is the part of a move that tells you whether anyone turned up for it.
Against its 52-week range of $60.10 to $156.00, today's price sits 29% of the way up it.
What can be sourced
The record shows 1 analyst action in the last fortnight, the most recent from Jason Mills at a $120.00 target on November 6th, 2026; open-market insider buying on file within the last 90 days.
None of that is proof of causation. A filing or a target change that lands near a move is context, and the market routinely moves on neither.
What it does do is separate a move with something behind it from one with nothing.
| Metric | Value | Context |
|---|---|---|
| Change today | +27.9% | Healthcare average -0.2% |
| Volume | 3,949,522 | 4.9x the 30-day average |
| Market cap | $3.06 billion | Medical - Devices |
| Range | $60.10 – $156.00 | 52 weeks |
What insiders have been doing
1 open-market insider transaction is on file for the last 90 days.
Insider activity before a move is the one piece of context that carries money behind it rather than an opinion.
It is also disclosed late, so proximity to today's move should not be read as foreknowledge.
- September 11th, 2026buyWeill David · Director$109,058Form 4
| Metric | Value | Context |
|---|---|---|
| Change today | +27.9% | Healthcare average -0.2% |
| Volume | 3,949,522 | 4.9x the 30-day average |
| Market cap | $3.06 billion | Medical - Devices |
| Range | $60.10 – $156.00 | 52 weeks |
The bottom line
A move with something on the record behind it. Whether it holds is a different question. Not investment advice. Summarized from public SEC Form 4 and congressional disclosure data and analyst ratings data.